68 results
8-K
EX-10.1
CGTX
Cognition Therapeutics Inc
20 Feb 24
Departure of Directors or Certain Officers
4:44pm
schedule specified in Appendix A or Paragraphs 3 and 4 of this Agreement. Upon Participant’s death during his or her continuous service with the Company … , any PRSUs that are outstanding and unvested immediately prior to Participant’s death will remain outstanding for ninety (90) days, during which time
8-K
EX-99.1
CGTX
Cognition Therapeutics Inc
4 Jan 24
Other Events
4:21pm
and inflammation, leading to RPE cell and photoreceptor cell death Cellular and Molecular Pathogenesis of Dry AMD American Medical Association. JAMA. 2011 … Knocking down TMEM97 rescues retinal pigment epithelial (RPE) cells from death by oxidative stress - Supports role of TMEM97 in dry AMD Literature
8-K
EX-99.1
CGTX
Cognition Therapeutics Inc
8 Aug 23
Cognition Therapeutics Reports Second Quarter 2023 Financial Results and Business Update
7:05am
and death in the progression of Alzheimer’s disease, dementia with Lewy bodies (DLB) and dry age-related macular degeneration (dry AMD). Additionally, we also
8-K
EX-99.2
5aaj37
28 Jun 23
Cognition Therapeutics Announces Positive Topline Results for CT1812 Phase 2 SEQUEL Study for Mild-to-Moderate Alzheimer’s Disease
7:27am
8-K
ce964 dvrjpd
12 Jun 23
Submission of Matters to a Vote of Security Holders
7:41am
8-K
EX-10.1
kodv 2n3u
1 May 23
Departure of Directors or Certain Officers
7:30am
8-K
EX-99.1
teobc02
19 Apr 23
Developing disease-modifying medicines for degenerative disorders Analyst Breakfast April 2023
7:30am
8-K
EX-99.1
gytwvqq o5r
16 Nov 22
Developing disease - modifying medicines for degenerative disorders November 2022
5:18pm
8-K
EX-1.1
8pb1l9m7k9vhrely
14 Nov 22
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
8:00am
424B4
jbi63w8n
14 Nov 22
Prospectus supplement with pricing info
6:02am
DRS
5kpjg
20 Oct 22
Draft registration statement
12:00am
8-K
3k97p
13 Jun 22
Submission of Matters to a Vote of Security Holders
5:07pm
DEF 14A
hvj51krdm hh
25 Apr 22
Definitive proxy
5:28pm
10-K
9c8o q3r6
30 Mar 22
Annual report
7:40am